UBS raised the firm’s price target on Adient (ADNT) to $33 from $32 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADNT:
- Adient reports Q2 adjusted EPS 52c, consensus 44c
- Adient raises FY26 revenue view to $14.8B from $14.6B, consensus $14.63B
- Adient acquires foam production plant in Romulus, MI from Woodbridge
- Adient price target lowered to $26 from $28 at JPMorgan
- Citi Says S&P 500 Is Headed to 7,700 – Here Are 2 Stocks to Buy Now